Brian Kaspar

Brian Kaspar is a leading researcher in the field of gene therapy for spinal muscular atrophy (SMA), known for his role in developing Zolgensma. His work was initially supported by the Gaynor family's charity, Sophia's Cure, but became controversial as he transitioned to a for-profit biotech company, AveXis.